L'intérêt à découvert pour TILT Holdings donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de TILT Holdings. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

TILT Holdings (OTC:TLLTF) Stock, Rapport sur les intérêts à découvert

TILT Holdings

TILT Holdings Inc is a business solutions provider to the cannabis industry. The company helps cannabis businesses build brands through a portfolio of companies providing technology, hardware, cultivation, and production. The operating segments of the company are Cannabis and Accessories. The majority of the revenue is generated from the Accessories segment which is engaged in the manufacturing and distribution of electronic, non-nicotine (i.e., cannabis) devices and systems. The company's geographical segments include the United States, Canada, and others, of which the majority of the revenue is generated from the United States.

TILT Holdings Inc

Mitsubishi Estate Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MITEY#OTC">MITEY</a>) reported quarterly earnings of $0.44 per share. This is a 8.33 percent decrease over earnings of $0.48 per share from the same period last year. The company reported $3.49 billion in sales this quarter. This is a 10.47 percent decrease over sales of $3.90 billion the same period last year.

Earnings

News

MITEY

Mitsubishi Estate Co Q4 EPS $0.44 Down From $0.48 YoY, Sales $3.49B Down From $3.90B YoY

<ul>
<li>TSLA</li>
<li>GLD</li>
<li>NVDA</li>
<li>BULL</li>
<li>GOOGL</li>
<li>GOOG</li>
<li>QQQ</li>
<li>AAPL</li>
<li>AMZN</li>
<li>MSTR</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

AAPL

AMZN

BULL

GOOG

GOOGL

MSTR

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of May 12, 2025 (Via Swaggy Stocks)

SHOP

Reported May 9, 2025: Shopify To Join The Nasdaq-100 Index Beginning May 19, 2025

Guggenheim analyst Michael Morris maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $675 to $725.

Price Target

Analyst Ratings

SPOT

Guggenheim Maintains Buy on Spotify Technology, Raises Price Target to $725

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRSN#NASDAQ">NRSN</a>) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at $1.0438 on Friday. <a href="https://www.benzinga.com/quote/NRSN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Jason McCarthy initiated coverage on ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) with a Buy rating and announced a price target of $3. ProMIS Neurosciences shares closed at $0.5020 on Friday. <a href="https://www.benzinga.com/quote/PMN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group initiated coverage on Primis Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) with a Buy rating and announced a price target of $1. Primis Finl shares closed at $8.96 on Friday. <a href="https://www.benzinga.com/quote/FRST/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NRSN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="606" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-1024x606.png" alt="" class="wp-image-911914" style="width:576px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-1024x606.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125-768x455.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12091931/image-125.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45342900/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-5">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Initiation

Markets

FRST

NRSN

This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/05/09/final-trades-vertex-pharma-palantir-wynn-resorts-and-microsoft.html">Halftime Report Final Trades</a>,&#8221; Brenda Vingiello, Chief Investment Officer of Sand Hill Global Advisors, picked Wynn Resorts, Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) as her final trade.
Wynn Resorts, on May 6, reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.19 per share. The company reported quarterly sales of $1.7 billion which missed the analyst consensus estimate of $1.74 billion.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here </a>
Stephen Weiss, Chief Investment Officer of Short Hills Capital Partners, named Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), <a href="https://in.benzinga.com/general/biotech/25/05/45208824/vertex-pharmaceuticals-stock-falls-on-q1-earnings-revenue-miss-company-raises-low-end-of-fy25-revenue-guidance">saying it will bounce</a>.
On the earnings front, Vertex reported first-quarter adjusted earnings per share of $4.06 on May 5, down from $4.76 a year ago and missing the consensus of $4.32. The cystic fibrosis-focused company reported sales of $2.77 billion, missing the consensus of $2.85 billion.
Kevin Simpson, Capital Wealth Planning CIO, said Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) reported impressive earnings, with revenue gaining 39% in the first quarter.
Citigroup analyst Tyler Radke raised the price target on the stock from $110 to $115 on May 8, supporting her view.
Jim Lebenthal of Cerity Partners, named Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) as his final trade.
On April 30, Microsoft reported stronger-than-expected financial results for the third quarter and also issued strong revenue guidance.
Price Action:
<ul class="wp-block-list">
<li>Vertex Pharmaceuticals shares fell 1.1% to close at $424.99 on Friday.</li>
<li>Palantir Technologies shares slipped 1.6% to settle at $117.30 during Friday's session.</li>
<li>Wynn Resorts shares rose 1.6% to close at $87.93 on Friday.</li>
<li>Microsoft shares climbed 0.1% to settle at $438.73.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a></li>
</ul>

Media

MSFT

PLTR

VRTX

WYNN

Wynn Resorts, Microsoft, Palantir And A Health Care Stock On CNBC's 'Final Trades'

Gryphon Digital Mining, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares are trading higher premarket at the last check on Monday after it disclosed a definitive stock-for-stock merger deal with American Bitcoin, a majority-owned subsidiary of Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/ac45343018/gryphon-digital-mining-announces-merger-with-american-bitcoin" rel="noreferrer noopener">for an undisclosed amount</a>.
Upon closing, the combined entity will operate under the American Bitcoin brand and is expected to trade on Nasdaq under the ticker &#8220;ABTC.&#8221;
Notably, in collaboration with Eric Trump, Hut 8 launched American Bitcoin earlier this year.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45324398/hut-8-analysts-still-bullish-despite-q1-miss-bets-on-american-bitcoin-hpc-ai-potential" rel="noreferrer noopener">Hut 8 Analysts Still Bullish Despite Q1 Miss; Bets On American Bitcoin, HPC/AI Potential</a>
This venture aims to establish the world&#8217;s largest and most efficient pure-play Bitcoin mining operation, complemented by a substantial strategic Bitcoin reserve.
American Bitcoin is specifically designed to facilitate Bitcoin accumulation at scale through cost-effective mining practices and other synergistic strategies.
The transaction is projected to close as early as the third quarter of 2025, contingent upon fulfilling certain closing conditions.
Upon the transaction&#8217;s completion, it is anticipated that existing Gryphon stockholders will hold roughly 2% of the combined company, while former American Bitcoin stockholders will own approximately 98%.
Asher Genoot, Board Member of American Bitcoin and CEO of Hut 8 said, &#8220;Time-to-market was a critical factor, and this transaction enables an efficient path to public markets by combining with an entity that is structurally aligned with American Bitcoin&#8217;s mining-focused launch strategy.&#8221;
As of March 31, cash and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/ac44571035/gryphon-digital-mining-reports-fourth-quarter-and-fy-2024-financial-results" rel="noreferrer noopener">cash equivalents stood at $735k</a>.
Price Action: GRYP shares are up 303.9% to $2.10 premarket at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/44849610/bitcoin-miners-buckle-under-april-price-pressure-but-jp-morgan-analyst-says-mara-cleanspark-held-strong" target="_blank" rel="noreferrer noopener">Bitcoin Miners Buckle Under April Price Pressure, But JP Morgan Analyst Says MARA, CleanSpark Held Strong</a></li>
</ul>
Image by Wit Olszewski via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Small Cap

Movers

GRYP

Gryphon Digital To Take Trump-Affiliated American Bitcoin Public In Merger Deal, Stock Soars

GD Culture Group Limited ("GDC" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>), and its subsidiary, AI Catalysis Corp. ("AI Catalysis"), today announced that it has entered into a Common Stock Purchase Agreement (the "Agreement") with an accredited investor (an "Investor"), a British Virgin Island limited liability company, providing for the sale by the Company of up to $300 million of its common stock.
Proceeds from the facility will be used to support the Company's crypto asset treasury strategy, including the purchase of Bitcoin ("BTC") and OFFICIAL TRUMP ("TRUMP"). Under this initiative, and subject to certain limitations, GDC intends to allocate a significant portion of the proceeds from any share sales under the facility to the acquisition, long-term holding, and integration of crypto assets into its core treasury operations. This strategic move reflects the Company's commitment to and confidence in the ongoing decentralization transformation.

GD Culture Group Announces $300M Common Stock Purchase Agreement with Accredited Investor; Proceeds To Be Used To Support Company's Crypto Treasury Expansion

The United States and China agreed to slash their retaliatory tariffs by over 100 percentage points, pausing a spiraling trade war that had threatened<a href="https://www.benzinga.com/news/econ-s"> to choke global growth.</a>
<h3 class="wp-block-heading">What's In The Deal?</h3>
The agreement establishes a 90-day reset, slashing U.S. tariffs on Chinese goods from 145% to 30%, and Chinese tariffs on U.S. goods from 125% to 10%, starting May 14. 
The decision stems from high-level negotiations in Geneva, led by U.S. Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng.
The truce halts one of the steepest protectionist escalations in recent history, following President Donald Trump's aggressive "Liberation Day" trade tariffs launched on April 2.
"We reached an agreement on a 90-day pause and substantially moved down the tariff levels," Bessent said in a press conference. 
"Both countries represented their national interests very well, but we concluded we have shared interest in balanced trade."
<h3 class="wp-block-heading">Tariff Truce Cools Recession And Inflation Risks</h3>
The tariff rollback offers more than diplomatic relief — it also addresses growing fears of a U.S. economic slowdown and resurgent inflation. By averting the triple-digit import taxes that threatened to choke global trade, the deal removes a significant source of economic uncertainty that had weighed on business investment and consumer confidence.
Recession probabilities have sharply declined in response. 
The latest market-based forecast from Kalshi shows a 46% chance of a U.S. recession this year, down from 60% at the end of April, reflecting improving sentiment. Notably, consumer spending and corporate earnings had begun showing early signs of strain under the tariff shock imposed in April.
On the inflation front, the agreement is expected to ease price pressures on goods most impacted by the trade war — including electronics, automotive parts and industrial equipment.
Ahead of Tuesday's official April Consumer Price Index report, economists expect a return to monthly inflation growth: headline prices are forecast to rise 0.3%, reversing March's 0.1% dip. Core inflation is also expected to rise 0.3%, while annual inflation rates are seen holding steady at 2.4% for headline and 2.8% for core.
<h3 class="wp-block-heading">Why Markets Cheered</h3>
U.S. equity futures soared as the news hit, with futures on the S&amp;P 500 climbing 3.13% to 5,836.66, those on the Nasdaq 100 jumping 4.05%, and Dow futures up 2.62%. 
The U.S. dollar index – as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – surged 1.4%, with the greenback rallying 2% against the Japanese yen. 
Meanwhile, 2-year Treasury yields rose 10 basis points to 4%, as traders dialed back expectations for a near-term Federal Reserve rate cut. The odds of a June cut fell to 11%, down from 25% a week ago, per CME FedWatch.
Gold – as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) – dropped 2.9%, with investors rotating out of safe havens, and oil climbed 3.9% to $63.40 amid improving global demand prospects.
<h3 class="wp-block-heading">Who Wins On Wall Street?</h3>
U.S. equities rallied sharply as investors welcomed the truce between Washington and Beijing. 
Trade-sensitive and consumer-facing stocks led the premarket advance, reflecting relief over lower input costs and reduced supply chain disruption. Technology and industrials also posted notable gains.
Top Gainers – S&amp;P 500
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stanley Black &amp; Decker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>)</td>
<td>+12.07%</td>
</tr>
<tr>
<td>Best Buy Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>)</td>
<td>+10.42%</td>
</tr>
<tr>
<td>Microchip Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)</td>
<td>+9.29%</td>
</tr>
<tr>
<td>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>)</td>
<td>+8.94%</td>
</tr>
<tr>
<td>NRG Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>)</td>
<td>+8.08%</td>
</tr>
</tbody>
</table>
</figure>
Top Premarket Gainers – Nasdaq 100
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microchip Technology Inc.</td>
<td>+9.29%</td>
</tr>
<tr>
<td>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>)</td>
<td>+8.94%</td>
</tr>
<tr>
<td>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>+8.44%</td>
</tr>
<tr>
<td>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td>+8.07%</td>
</tr>
<tr>
<td>ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>)</td>
<td>+8.02%</td>
</tr>
</tbody>
</table>
</figure>
Top Premarket Losers – S&amp;P 500
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>)</td>
<td>-5.24%</td>
</tr>
<tr>
<td>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</td>
<td>-3.60%</td>
</tr>
<tr>
<td>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)</td>
<td>-3.58%</td>
</tr>
<tr>
<td>Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</td>
<td>-3.38%</td>
</tr>
<tr>
<td>Westinghouse Air Brake Technologies Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>)</td>
<td>-3.17%</td>
</tr>
</tbody>
</table>
</figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">Apple, Amazon, Nvidia Rise In Monday Premarket As US, China Agree To 90-Day Tariff Truce: &#8216;Neither Side Wants A Decoupling&#8217;</a><span class="author" style="box-sizing: border-box; border: 0px solid rgb(229, 231, 235); --tw-scale-x: 1; --tw-scale-y: 1; --tw-pan-x: ; --tw-pan-y: ; --tw-pinch-zoom: ; --tw-scroll-snap-strictness: proximity; --tw-gradient-from-position: ; --tw-gradient-via-position: ; --tw-gradient-to-position: ; --tw-ordinal: ; --tw-slashed-zero: ; --tw-numeric-figure: ; --tw-numeric-spacing: ; --tw-numeric-fraction: ; --tw-ring-inset: ; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgba(59,130,246,.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; --tw-blur: ; --tw-brightness: ; --tw-contrast: ; --tw-grayscale: ; --tw-hue-rotate: ; --tw-invert: ; --tw-saturate: ; --tw-sepia: ; --tw-drop-shadow: ; --tw-backdrop-blur: ; --tw-backdrop-brightness: ; --tw-backdrop-contrast: ; --tw-backdrop-grayscale: ; --tw-backdrop-hue-rotate: ; --tw-backdrop-invert: ; --tw-backdrop-opacity: ; --tw-backdrop-saturate: ; --tw-backdrop-sepia: ; --tw-contain-size: ; --tw-contain-layout: ; --tw-contain-paint: ; --tw-contain-style: ;"></li>
</ul>
Photo: emin kuliyev/Shutterstock

Government

Regulations

Bonds

Forex

Econ #s

ETFs

ABBV

GEHC

GILD

MCHP

PowerShares DB US Dollar Index Bullish Fund

Wall Street Rips Higher As Tariff Truce Halts US–China Economic Escalation

WIIM

Gryphon Digital Mining shares are trading higher after the company announced a merger agreement with American Bitcoin.

FEATURING ALL OF FOX'S PREMIUM NEWS, SPORTS AND ENTERTAINMENT PROGRAMMING IN ONE DYNAMIC PLATFORM
NEW YORK and LOS ANGELES, May 12, 2025 /PRNewswire/ -- Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>, FOX)))&nbsp;today introduced FOX One, its wholly-owned direct to consumer streaming service. FOX One will bring all of FOX's leading News, Sports and Entertainment branded content together in one dynamic streaming platform.&nbsp;
For the first time, cord-cutters and cord-nevers will have live streaming and on-demand access to the full portfolio of FOX brands including FOX News, FOX Business, FOX Weather, FOX Sports, FS1, FS2, BTN, FOX Deportes, FOX Local Stations and the FOX network as well as the option to bundle FOX Nation within one platform.

FOXA

FOX Launches 'FOX One' Direct-To-Consumer Streaming Service Combining Live And On-Demand Access To Entire Portfolio Including FOX News, FOX Sports, FOX Entertainment, Local Stations, FS1, FS2, FOX Weather, And More

SDRL

Seadrill shares are trading lower following a Q1 EPS miss.

Goldman Sachs analyst Olivier Nicolai upgrades Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) from Neutral to Buy and raises the price target from $70.1 to $88.

Upgrades

Goldman Sachs Upgrades Anheuser-Busch InBev to Buy, Raises Price Target to $88

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4424402-1&amp;h=1455207525&amp;u=http%3A%2F%2Fwww.zynex.com%2F&amp;a=Zynex%2C+Inc">Zynex, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>),&nbsp;an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for its NiCO&#x2122;, Noninvasive CO-Oximeter device.
This submission marks a historic milestone in the evolution of pulse oximetry and a major breakthrough for the Company in its mission to improve the quality of care and patient outcomes through its patient monitoring products. Pulse oximetry is one of the world's largest medical device markets and current devices on the market have long been under scrutiny for their inaccuracy and limitations. Zynex's laser technology enables oxygen levels to be measured accurately for patients with dark skin. In cases of carbon monoxide (CO) poisoning, not only are the measurements non-invasive and results instantaneous, but both oxygen and CO are measured accurately, potentially reducing the need for taking blood samples and having to wait for the lab results.
 &nbsp;

ZYXI

Zynex Submits 510(k) Application To FDA For NiCO, Noninvasive Co-Oximeter Device

LINC

Lincoln Educational Services shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates.

As of May 12, 2025, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>)</h3>
<ul class="wp-block-list">
<li>On May 6, Astera Labs posted better-than-expected quarterly results. &#8220;Astera Labs started the year strong, with Q1 revenue growing 13% sequentially and 144% year-over-year, and exceeding our first quarter guidance for gross margin and earnings per share,&#8221; said Jitendra Mohan, Astera Labs&#8217; Chief Executive Officer. The company's stock jumped around 20% over the past month and has a 52-week high of $147.39.</li>
<li>RSI Value: 70.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ALAB Price Action: Shares of Astera Labs closed at $71.20 on Friday.</li>
<li>Edge Stock Ratings: 34.53 Momentum score with Value at 7.74. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/ALAB"><img loading="lazy" decoding="async" width="486" height="157" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12083959/image-120.png" alt="" class="wp-image-911845" style="width:375px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12083959/image-120.png 486w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12083959/image-120-300x97.png 300w" sizes="(max-width: 486px) 100vw, 486px" /></a></figure>
<h3 class="wp-block-heading">Microchip Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)</h3>
<ul class="wp-block-list">
<li>On May 8, Microchip Technology reported better-than-expected fourth-quarter sales results and issued first-quarter EPS and revenue guidance above estimates. Steve Sanghi, Microchip&#8217;s CEO and President commented, Our March quarter revenue of $970.5 million exceeded the midpoint of our guidance, and we believe marks the bottom of this prolonged industry down cycle for Microchip.&#8221; The company's stock gained around 42% over the past month and <a href="https://www.benzinga.com/quote/MCHP">has a 52-week high</a> of $100.56.</li>
<li>RSI Value: 80.2</li>
<li>MCHP Price Action: Shares of Microchip Technology closed at $55.33 on Friday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45342900/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-5">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

ALAB

Top 2 Tech Stocks That May Crash In Q2

Pan American Silver Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) and MAG Silver Corp. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MAG#AMEX">MAG</a>) disclosed a definitive deal for Pan American to acquire MAG Silver&#8217;s <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45339398/pan-american-silver-announces-agreement-to-acquire-mag-silver-corp" rel="noreferrer noopener">shares through a plan of arrangement</a>.
As per the deal, MAG shareholders will receive approximately $2.1 billion ($20.54 per MAG share based on PAAS&#8217;s May 9, 2025 NYSE closing price) in a mix of $500 million cash and 0.755 PAAS shares per MAG share (subject to proration).
This represents ~21% and ~27% premiums to MAG&#8217;s May 9, 2025 NYSEAM closing price and 20-day VWAP, respectively.
Also Read: <a href="https://www.benzinga.com/government/regulations/25/04/44903750/gold-price-soars-to-record-highs-eyes-best-2-month-rally-since-2011-on-blockbuster-etf-buying">Gold Price Soars To Record Highs, Eyes Best 2-Month Rally Since 2011 On Blockbuster ETF Buying</a>
Post-transaction, MAG shareholders will own ~14% of the enlarged, diversified Pan American, gaining exposure to a larger silver and gold producer.
The acquisition significantly enhances Pan American&#8217;s value by adding a 44% stake in Juanicipio, a premier, low-cost, high-grade silver mine in Mexico with substantial exploration potential, operated by Fresnillo.
This is expected to add forecasted production of 6.5-7.3 Moz of silver to Pan American Silver in 2025 and 58 Moz proven and probable reserves, 19 Moz measured and indicated resources, and 35 Moz inferred resources.
Notably, Juanicipio&#8217;s high-margin ounces, with projected 2025 cash costs of ($1.00)-$1.00/oz and all-in sustaining costs of $6.00-$8.00/oz, are a logical fit within Pan American&#8217;s Americas-focused silver portfolio.
The MAG acquisition should significantly boost Pan American&#8217;s 2025 free cash flow (+$98 million pro forma) and offer significant exploration upside (Juanicipio, Deer Trail, Larder), strategically deploying $500 million of PAAS&#8217;s cash for increased silver exposure and growth.
Michael Steinmann, President and CEO of Pan American, said, &#8220;Juanicipio is a large-scale, high-grade, low-cost silver mine that will meaningfully increase Pan American&#8217;s exposure to high-margin silver ounces. Furthermore, we see future growth opportunities through the significant exploration potential at Juanicipio as well as MAG&#8217;s Deer Trail and Larder properties. This strategic acquisition further solidifies Pan American as a leading Americas-focused silver producer.&#8221;
As of March 31, PAAS&#8217; cash and short-term <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45270191/pan-american-silver-reports-unaudited-first-quarter-2025-results" rel="noreferrer noopener">investments stood at $923.0 million</a>.
Price Action: PAAS shares are down 7.24% to $25.24, while MAG shares are up 13% to $19.12 premarket at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45337711">Pony AI, Lyft And Sunrun Are Among Top 9 Mid-Cap Gainers Last Week (May 5-May 9): Are The Others In Your Portfolio?</a></li>
</ul>
Image via Shutterstock

Large Cap

Commodities

PAAS

Pan American Acquires MAG For $2.1 Billion

Lixte Biotech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) reported quarterly losses of $(0.29) per share. This is a 32.56 percent increase over losses of $(0.43) per share from the same period last year.

LIXT

Lixte Biotech Hldgs Q1 EPS $(0.29) Up From $(0.43) YoY

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12074722/MGM.jpeg" alt="" class="wp-image-12784" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12074722/MGM.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12074722/MGM-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12074722/MGM-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
Once a favorite of investment banks for its strong post-pandemic performance, MGM China's business started to contract in the first quarter of 2025
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>MGM China's revenue fell 3% in the first quarter, as Macao's post-pandemic rebound lost momentum</li>
<li>Revenue from the casino operator's VIP rooms plummeted by 50% during the quarter, far worse than a 10% decline for rival Sands China</li>
</ul>
After smiling on Macao for the last two years after China ended its strict pandemic restrictions, Lady Luck has found better places to cast her gaze these days than Asia's leading gambling enclave.
The city's gaming revenue began to slow down notably this year as the rebound faded and China's slowing economy further dampened demand, hurting business for its casino operators.&nbsp;MGM China Holdings Ltd.&nbsp;(2282.HK), previously an investor favorite, has become the latest to get dragged into the slowdown, reporting year-on-year revenue and profit declines its latest&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0501/2025050100033.pdf">first-quarter results</a>.
The company's revenue slipped 3.2% to nearly HK$8 billion ($1.02 billion) in the three months to March, while its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) sagged 5.5% to HK$2.37 billion, according to the report released earlier this month. The company blamed the revenue drop on a decrease in bets on main floor table games.
MGM China operates two casinos in Macao: the MGM Macao on the Macao Peninsula, where main floor table games bets decreased by 7.4% year-on-year during the quarter to HK$13.37 billion; and the MGM Cotai on the Cotai Strip, where main floor table games bets fell by nearly 4% to HK$14.85 billion.
<h4 class="wp-block-heading">VIP business plunge</h4>
While gaming was off on its main casino floors, the situation was even worse for its VIP business catering to high rollers. At MGM Macao, VIP turnover plunged by nearly half from HK$12.15 billion in the first quarter of 2024 to HK$6.24 billion in the first three months of this year. MGM Cotai's VIP turnover also halved from HK$53 billion to HK$26.27 billion over the period, suggesting that high-rollers weren't being as free-spending as they were during headier times when China's economy was booming.
While MGM China did not specify why its VIP business fell so sharply, rival&nbsp;Sands China&nbsp;(1928.HK) reported a much milder 10% year-on-year decline in its VIP revenue during the quarter. That seems to show that MGM China's VIP business plunge owned not only to lower traffic from China's high-rolling crowd, but also from competitors stealing its business.
Beyond its core gaming business, MGM China's hotel operations also sagged. Despite maintaining average occupancy rates of over 93% during the quarter, on par with a year earlier, the company's revenue per available room (revpar), which also factors in room prices, fell sharply. MGM Cotai's revpar dropped by 21% from HK$2,631 in the first quarter of 2024 to HK$2,066 in the latest period, while MGM Macao's revpar tumbled by an even higher 23% from HK$3,061 to HK$2,346 over that time.
<h4 class="wp-block-heading">Falling citywide revenue</h4>
While its VIP business is clearly facing company-specific issues, MGM China's bigger challenge – being faced by all in the market – is the broader Macao gaming market slowdown. All casino operators have also struggled to adjust following big changes in Macao's gaming regulations several years ago.
Those changes saw a ban on outsourcing VIP room operation, and limited junket operators to collect flat commissions from business they brought in without any profit-sharing. Meanwhile, China's own crackdown on marketing of cross-border gambling has further pressured the operators. Those factors, combined with the more recent economic slowdown, make it unlikely that Macao will ever return to its peak of 300 billion patacas ($37.4 billion) in annual gaming revenue.
The city's gross gaming revenue last month edged up 1.7% year-on-year to 18.86 billion patacas, but was down 4.1% month-on-month, marking a second consecutive sequential decline, according to the Macao Gaming Inspection and Coordination Bureau. That weakness is overshadowing the entire industry.
Macao's government estimated at the end of last year that gaming revenue would reach 240 billion patacas in 2025, up 11% year-on-year. To reach that figure, monthly gaming revenue would need to average 20 billion patacas. However, in the first four months of 2025, monthly gaming revenue has consistently fallen short of that amount, casting doubt on whether the annual target is attainable.
<h4 class="wp-block-heading">A lose-lose trade war</h4>
The U.S.-China trade war has also cast a shadow over Macao's gaming industry. While Macao doesn't conduct much direct trade with the U.S. and relies heavily on gaming for 80% of economic activity, the trade war is dragging down the whole global economy that supplies the gamblers who come to the city. Slowdowns in the Chinese and other global economies mean lower budgets for travel and consumption, which is likely to reduce the number of visitors to Macao, as well as their gaming budgets.
Macao's top government official Sam Hou Fai previously said escalation of the U.S.-China trade war would have limited direct impact on the city. But he also acknowledged that Macao could be affected indirectly by falling interest in the local tourism and gaming industries.
The economic impact of the U.S. tariff hikes has yet to clearly manifest itself, since the major increases occurred just last month. But many expect the effects to start showing up in the next six months to a year, with some countries like to report slipping into recession. Consumer sentiment is likely to weaken as that happens, further dampening demand for leisure travel.
When Macao's six major casino operators renewed their gaming licenses in 2023, MGM China was feted as the biggest winner, as the government boosted the company's licensed gaming tables by 36% to 750. That briefly made it an investor darling, as many bet the company would put those added tables to good use during the city's rebound. But with the industry now slowing, and pressure mounting on MGM China's VIP business, the casino operator, known for its lion logo, may rapidly be losing its roar.

Asia

Gaming

Opinion

Macao's Gaming Fatigue Takes The Roar Out Of MGM China

Canaccord Genuity analyst Maria Ripps maintains Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and raises the price target from $12 to $14.

NEXN

Canaccord Genuity Maintains Buy on Nexxen International, Raises Price Target to $14

Press Releases

General

Commonwealth Alternative Care Aims High for Fall Community Engagement

Management

TILT Holdings Announces the Departure of its Chief Revenue Officer

TILT Sets Third Quarter 2024 Conference Call for November 14 at 5:00 p.m. ET

TILT Holdings Reports Third Quarter 2024 Results and Announces Strategic Review of its Plant-Touching Business

Contracts

TILT Holdings Signs Definitive Agreement to Divest Retail Locations in Massachusetts to In Good Health for $2 Million

TILT Sets Fourth Quarter and Full Year 2024 Conference Call for March 19 at 5:00 p.m. ET

TILT Holdings Reports Fourth Quarter and Full Year 2024 Results

TILT Holdings Receives Default Notice from Innovative Industrial Properties

TILT Sets First Quarter 2025 Conference Call for May 15 at 5:00 p.m. ET

Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe's First Handheld Liquid Inhalation Device

TLLTF

TSX:CURA

Comments

TILT Holdings

Intérêt court

TILT Holdings (OTC:TLLTF) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL